Clinical Trial Update: Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating ACE inhibitors in patients on hemodialysis for left ventricular hypertrophy and hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Left Ventricular Hypertrophy, Hypertension | Phase 3 | Status: COMPLETED